The overall common effect estimate (OR = 1.27, 95% CI: 1.18–1.37) confirms that these adiponectin-related genetic variants function as obesity susceptibility loci in PCOS. The gene discussed is ADIPOQ; the disease is polycystic ovary syndrome.